Application 214058
- Type
- ANDA
- Sponsor
- CIPLA LIMITED
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | EMTRICITABINE; RILPIVIRINE; TENOFOVIR ALAFENAMIDE | EMTRICITABINE;RILPIVIRINE;TENOFOVIR ALAFENAMIDE | TABLET;ORAL | 200MG;25MG;25MG | No | No |
Source provenance: Browse the complete Orange Book source catalog.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
Document, Submission type, Date table| Document | Submission type | Date |
|---|
| 72735 | ORIG | 2022-11-28 |